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Summary
Human vitronectin (hVN) is a glycoprotein that functions as a cell adhesion molecule and a
regulator of coagulation in blood plasma and the extracellular matrix. In vitro, hVN is added to
serum-free media in order to promote the adhesion of animal cells to tissue culture surfaces
and the proliferation of undifferentiated stem cells. Here, we report the production of hVN in
Nicotiana benthamiana using the inducible In Plant ACTivation (INPACT) hyperexpression
platform. N. benthamiana plants were transformed with an INPACT expression cassette
encoding hVN, and both the Tobacco yellow dwarf virus Rep/RepA activator and Tomato bushy
stunt virus p19 gene under the transcriptional control of the ethanol-inducible AlcR:alcA gene
switch. hVN expression was maximal 4–5 days postactivation of the INPACT platform with a
dilute ethanol solution, and crude yields of the recombinant protein reached a maximum of
643  78 mg/kg fresh weight. A three-stage purification protocol was developed using
heparin and polyhistidine tag affinity binding and size exclusion filtration, resulting in a plant-
made hVN product of >90% purity. Storage conditions for plant-made hVN were identified
that maximized the capacity of the recombinant protein to promote cell adhesion. Critically,
plant-made hVN was shown to be functionally equivalent to commercial, plasma-derived hVN
at promoting one-half maximal attachment of murine fibroblast cells (BALB-C/3T3) in serum-
free medium at <0.1 lg/cm2 to tissue culture plasticware. The INPACT platform represents an
attractive means of producing large quantities of functional, animal-free hVN for in vitro
applications.
Introduction
Human vitronectin (hVN), formerly known as serum spreading
factor, is one of the major cell adhesion proteins found in the
blood and the extracellular matrix (Conlan et al., 1988; Shaffer
et al., 1984). Nascent hVN is converted to its mature form via
cleavage of a 19-amino acid secretion signal peptide at the
N-terminus. Circulating hVN occurs predominantly as a mono-
meric polypeptide (75 kDa) or as two polypeptides (65 and
10 kDa) linked by a disulphide bond (Tollefsen et al., 1990) and
provides a regulatory link between a wide range of biological
activities, including tissue repair, angiogenesis, haemostasis and
metastasis (Schvartz et al., 1999). hVN interacts with diverse
proteins via conserved regions located throughout the polypeptide
chain (Jin and Varner, 2004; Preissner, 1991; Zhou et al., 2003)
and the carboxyl-terminal region contains a cryptic, arginine-rich
domain that binds heparin, an anticoagulant. This domain is only
exposed after hVN binding to the thrombin–antithrombin III
complex in vivo or denaturation with urea, heat, or acid in vitro,
and it is this conformational change that activates self-association
of hVN into multimers with significantly increased affinity for
heparin compared to the monomeric form (Preissner, 1991).
Vitronectin (VN) has been isolated from a range of mammalian
sources and utilized for both research and clinical applications
because of its adhesive properties. VN is most commonly used in
animal cell culture to coat tissue culture surfaces in order to
promote cell adhesion and induce cell spreading (Underwood and
Bennett, 1989). Recombinant VN and its variants have also been
used in combination with defined culture media to maintain
pluripotency and growth of pluripotent stem cells (Li et al., 2010).
Fusion of hVN to insulin-like growth factor (IGF), IGF-binding
proteins and epidermal growth factor significantly enhances
proliferation and migration of primary skin keratinocytes and the
re-epithelialization of wounds (Hollier et al., 2005; Upton et al.,
2008; Xie et al., 2010). As a result, clinical hVN-based treatments
for improved wound management and healing have been
developed, particularly where cell proliferation is required and/
or wound repair has been delayed, such as in burns or ulcers
(Upton et al., 2011). Further, hVN and its derivatives have been
used to promote osseointegration of implantable devices by
improving surface–cell interactions and increasing implant con-
nectivity with surrounding bone (Cacchioli et al., 2009). hVN in its
native form is traditionally purified from human blood plasma. As
such, the protein must undergo strict regulatory testing for
infectious agents and has become prohibitively expensive for
applications in translational animal research.
Plant-based protein production is a convenient means of
manufacturing therapeutics and nontherapeutics normally iso-
lated from animal sources, including blood plasma or tissues.
Production in plants minimizes the risk of contamination with
animal pathogens and obviates the need for expensive serological
screening and more extensive purification. Such quality control
394 ª 2017 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
Plant Biotechnology Journal (2018) 16, pp. 394–403 doi: 10.1111/pbi.12779
processes are typically required for animal-derived protein prod-
ucts destined for use in animal or human therapeutics. However,
the economic feasibility of plant-based protein production relative
to conventional bacteria, yeast or insect cell bioreactor systems is
fundamentally dependent upon recombinant protein yield. The
use of plant viral vectors to amplify transgene copy number and
virus-derived gene products to suppress post-transcriptional gene
silencing (PTGS), an innate plant defence pathway that can
specifically target transgene mRNA for degradation, has improved
recombinant protein yields such that plants are becoming a
competitive platform for the production of biologically equivalent
proteins. Recent ‘deconstruction’ of the genomes of both DNA
and RNA plant viruses has allowed the development of plant viral
transgene expression vectors adapted for either short-term,
transient or long-term, stable protein production in plants
(reviewed in Lico et al., 2008 and Mortimer et al., 2015).
We recently described the In Plant ACTivation (INPACT)
platform, an inducible, high-level expression system for trans-
genic plants based upon the disaggregated DNA genome of a
geminivirus, Tobacco yellow dwarf virus (TYDV) (Dugdale et al.,
2013, 2014). The INPACT platform is unique in that the gene of
interest is split and arranged such that its expression only occurs
from extrachromosomal episomes that are released from the host
chromosome in the presence of the TYDV-encoded replication-
associated proteins, Rep and RepA. Temporal control of Rep/
RepA expression is achieved using the ethanol-responsive alc
gene switch. Essentially, the INPACT platform provides the
benefits of transient transgene expression in a stably transformed
plant, thereby disconnecting plant growth from recombinant
protein production. Nicotiana benthamiana transformed with an
INPACT platform encoding hVN and activated with a dilute
ethanol solution reached maximum crude yields of ~100 mg hVN/
kg fresh weight (FW) (Dugdale et al., 2013). In the present study,
we have integrated the gene encoding Tomato bushy stunt virus
(TBSV) p19, a suppressor of PTGS, into the INPACT platform and
describe its effects on recombinant hVN accumulation in
N. benthamiana. The inclusion of TBSV p19 into the INPACT
expression platform significantly increased maximum production
of recombinant hVN by ~sixfold. A simple, three-stage hVN
purification process was developed, and the ability of plant-made
hVN to promote the attachment of murine fibroblast cells to
tissue culture surfaces was compared to commercial hVN isolated
from human plasma. The results demonstrate the potential of the
INPACT expression platform for biopharming animal proteins in
planta.
Results
Production of transgenic N. benthamiana plants
containing an enhanced INPACT platform encoding hVN
Synchronized activation of transgene amplification and expres-
sion from the INPACT platform is strongly dependent on the
regulated expression of Rep/RepA activator genes. As such, the
identification of elite N. benthamiana parent lines transformed
with the ethanol-inducible TYDV Rep/RepA cassette (pAlc-Rep/
RepA; Figure 1) was critical. Elite lines must satisfy two major
criteria: (i) minimal Rep/RepA expression in the absence of the
ethanol inducer molecule but rapid activation postethanol appli-
cation, and (ii) minimal negative physiological impact of Rep/RepA
accumulation on the plant, as overexpression of these gene
products can be phytotoxic and cause rapid yellowing and
necrosis (Dugdale et al., 2013). Transgenic N. benthamiana
plants (NbAlc-1, -2, -3, -4 and -5) containing the ethanol-
inducible TYDV Rep/RepA cassette were generated using
Agrobacterium tumefaciens-mediated leaf disc transformation,
acclimatized in soil and activated with a 5% (v/v) ethanol foliar
spray. Three days postethanol application, RNA was extracted
from leaves and used as the template in a reverse transcription-
polymerase chain reaction (RT-PCR) with primers specific for Rep/
RepA gene sequences. Rep/RepA transcripts, indicated by an
~750-bp RT-PCR product, were detected in four of the five plants
(NbAlc-1, -2, -4 and -5) following ethanol application
(Appendix S1). No PCR product was observed in RT-PCRs without
reverse transcriptase, indicating the absence of contaminating
gDNA. RNA extracted from N. tabacum line NtSRN-2 (a tobacco
line containing the same pAlc-Rep/RepA cassette) provided the
positive control for the RT-PCR. This tobacco line has been
previously shown to express Rep/RepA by quantitative real-time
PCR (qRT-PCR) following ethanol induction (Dugdale et al.,
2013). Based upon the abundance of Rep/RepA transcripts in
the RT-PCR and the absence of an abnormal phenotype associ-
ated with Rep/RepA accumulation, NbAlc-1 was selected as the
elite line for supertransformation with the modified INPACT
platform encoding hVN.
Agrobacterium-mediated transformation was used to super-
transform leaf discs from NbAlc-1 with the modified INPACT
platform encoding hVN and containing the TBSV p19 gene
under the transcriptional control of the alcA promoter
(pINPACT-hVN2, Figure 1). To facilitate accumulation of hVN,
the native N-terminal secretion signal was preserved and an ER
alcAPnosT nosT35SP alcR TYDV Rep/RepA
TYDV LIR
alcAP TBSV p19 nosT nosT
Syntron 3’ half TYDV SIR
hVN exon 2
Syntron 5’ half
TYDV LIR
hVN exon 135SP
pAlc-Rep/RepA
pINPACT-hVN2 Native secretion signal6XHIS-KDEL
Figure 1 Schematic representation of the ethanol-inducible Rep/RepA activator cassette (pAlc-Rep/RepA) and the modified INPACT cassette encoding
hVN and p19 (pINPACT-hVN2). 35SP = CaMV 35S promoter, nosT = nopaline synthase gene terminator, alcAP = alcA:minimal CaMV 35S promoter fusion,
alcR = gene encoding the alcohol receptor transcription factor, TYDV Rep/RepA = gene encoding the Tobacco yellow dwarf virus Rep/RepA activator
proteins, TBSV p19 = gene encoding the Tomato bushy stunt virus 19 K protein, TYDV LIR = Tobacco yellow dwarf virus large intergenic region,
syntron = synthetic intron, hVN exon = part of gene encoding the human vitronectin protein, TYDV SIR = Tobacco yellow dwarf virus small intergenic
region, 6XHIS = polyhistidine affinity tag, KDEL = ER retention signal.
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retention signal (KDEL) added to the C-terminus. For purifica-
tion purposes, a C-terminal polyhistidine affinity tag (6XHIS) was
also included. Following cleavage of the 19-amino acid secre-
tion signal, plant-made hVN has an approximate size of 469
amino acids and an estimated glycan-free molecular weight of
53.63 kDa. Eleven independent N. benthamiana lines
were regenerated on media containing both kanamycin and
hygromycin.
Identification of elite INPACT supertransformed lines
Detached leaves from the eleven transgenic N. benthamiana
lines were excised and tested for ethanol-induced accumulation
of recombinant hVN. Leaves were incubated on MS0 solid
media with small wells containing 5% (v/v) ethanol. Total
soluble protein (TSP) was extracted 5 days postactivation and
recombinant hVN levels determined by immunoblotting with an
hVN-specific monoclonal antibody. One line, T0-2, was identi-
fied as a high hVN-expressing INPACT plant (results not shown)
and grown to maturity. Southern hybridization analysis using
probes specific for either the nptII selection gene (within the
pAlc-Rep/RepA T-DNA) or hVN gene (within the pINPACT-hVN2
T-DNA) showed this elite line contained a single integrated copy
of both the pAlc-Rep/RepA and pINPACT-hVN2 cassettes
(Appendix S2). Line T0-2 was selfed, and the resulting 16 T1
generation events were screened for hVN accumulation using
the same method as was used to analyse the T0 events. Three
events expressing the highest levels of hVN (T1-8, T1-13 and T1-
15) were selected by immunoblotting (Appendix S3). These lines
were selfed and three T2 generation events (T2-1, T2-2 and T2-3)
identified as high-expressing hVN plants. All generations of
transgenic plants developed normally and appeared phenotyp-
ically similar to wild-type N. benthamiana plants in tissue culture
and soil. Normal growth and development of transgenic plants
was also observed in subsequent T3 generation plants grown in
soil (Appendix S4).
Ethanol-activated expression of p19 and Rep/RepA in
elite INPACT plants
Detached leaves from T2 progeny plants, designated T2-1, T2-2
and T2-3, were activated in vitro by incubation in liquid MS0
media containing 0.5% (v/v) ethanol for 5 days. RNA was
extracted from leaves pre- (Day 0) and postethanol (Day 5)
activation and analysed by RT-PCR (Figure 2). p19 transcripts
(as indicated by a ~ 550-bp RT-PCR product) were detected in
all transgenic progeny at Day 0, suggesting ‘leaky’ expression
in the absence of the ethanol inducer molecule (Figure 2a). The
relative abundance of these RT-PCR products, however,
increased by Day 5 suggesting that the addition of ethanol
does increase alcA-directed p19 expression. In contrast, no Rep/
RepA expression was observed prior to ethanol activation, and
Rep/RepA transcripts were relatively abundant after activation
(as indicated by a ~450-bp RT-PCR product; Figure 2b). The
sizes of the RT-PCR products for both p19 and Rep/RepA were
smaller than the PCR products amplified using plasmid DNA as
templates, indicating correct processing of both the syn-
thetic and TYDV Rep introns, respectively. No RT-PCR products
were observed in reactions using wild-type N. benthamiana
RNA as the template. RT-PCR products (~400 bp) were
obtained from all plant RNAs using primers designed to
amplify the actin housekeeping gene (Figure 2c). No RT-PCR
products were observed in the absence of the reverse
transcriptase enzyme.
Kinetics of recombinant hVN accumulation and ethanol
dose–response
The kinetics of recombinant hVN accumulation were assessed by
incubating transgenic leaf material from elite T0 generation line T0-
2 in liquid MS0 solution containing 0.5% (v/v) ethanol for 3, 4, 5, 6
and 7 days. hVN accumulation in leaf total soluble protein (TSP)
extracts was measured by immunoblotting (Figure 3a). Maximum
accumulation of the 75-kDa form of recombinant hVN was
observed 4–5 days after INPACT activation based on immunoblot
signal intensities. Ethanol dose–response was assessed by incu-
bating leaf material from the same plant in liquid MS0 solution
containing increasing concentrations of ethanol (0.1%, 0.25%,
0.5%, 1.0% and 2.0% (v/v)). Five days after activation, hVN
accumulation was measured in leaf TSP extracts by immunoblot-
ting (Figure 3b). Maximum accumulation of the 75-kDa form of
recombinant hVN was observed using 0.5% (v/v) ethanol based on
immunoblot signal intensity. Interestingly, high molecular weight
hVN forms and an ~60 kDa hVN degradation product were also
observed after immunoblotting. These extraneous hVN forms are
likely multimers of hVN formed by self-association under nonde-
naturing extraction conditions and a proteolytic cleavage product
as a result of the freeze-and-thaw process prior to SDS-PAGE and
immunoblotting, respectively.
0.5
0.5
0.5
– +  – +   – +   – +   – +  – +  – +   – +    –ve +veM
WT    T2-1  T2-2  T2-3    WT  T2-1  T2-2  T2-3
DAY 0 DAY 5
(a)
(b)
(c)
Figure 2 RT-PCR to detect p19 and Rep/RepA expression in high-
expressing INPACT lines following ethanol activation. Detached leaves of T2
generation INPACT lines (T2-1, T2-2, and T2-3) were activated with a 0.5%
(v/v) ethanol solution and sampled at 0 and 5 days postactivation. RNA was
isolated from leaf samples and p19 (top panel), Rep/RepA (middle panel)
and actin housekeeping (bottom panel) gene expression detected by RT-
PCR. Amplified products were electrophoresed through a 1.5% agarose
and stained with SYBR Safe DNA gel stain (Life Technologies). For PCR
controls, water was used as the negative control (ve) and 50 ng of
plasmid DNA containing the p19 gene (with syntron), TYDV RepRepA or
actin genes were used as the positive controls (+ve). RT-PCR without
reverse transcriptase (); RT-PCR with reverse transcriptase (+);
M = GeneRuler 1-kb DNA ladder (Life Technologies); WT, wild type.
Molecular weights marked in kb.
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Estimation of hVN crude yield
Yield estimates of plant-made hVN were obtained using T3
generation plantlets. Seed from three independent T2 generation
plants (T2-1, T2-2 and T2-3) were sown onto MSO media
containing both kanamycin and hygromycin antibiotics and
100% of the seed germinated within 1 week. This suggested
all T3 generations plants contained both gene cassettes. Eight
seedlings representing each T2 parent plant were randomly
selected. Detached leaves from in vitro plants were activated for
5 days in liquid MS0 media containing 0.5% (v/v) ethanol. Leaf
material from the eight seedlings was pooled (designated Batches
T3-1, T3-2 and T3-3) and hVN levels in the TSP compared to
known quantities of commercial, pure hVN (Promega) by SDS-
PAGE and immunoblotting (Figure 3c). The use of denaturing
buffer to extract plant-made hVN and the immediate analysis of
these extracts by SDS-PAGE resulted in a single 75-kDa band on
the immunoblot. The commercial hVN standard appeared as a
doublet because human-derived hVN is clipped into two major
products of 75 kDa and 65 kDa. A ChemiDoc imaging system
(Bio-Rad) was used to estimate the amount of hVN in TSP extracts
by comparing signal intensity to the hVN standard curve ranging
from 50 to 500 ng. This entire process was performed three times
on separate occasions. The estimated hVN yields (expressed as
mean  standard error) from Batches T3-1, T3-2 and T3-3 over
three independent experiments were 577  162, 709  155,
642  40 mg/kg (FW) of leaf, respectively (Table 1). Statistical
analysis indicated there was no significant difference in yields
between batches of T3 generation seedlings (P > 0.05), suggest-
ing consistent activation and expression in this generation of
plants. The overall estimated average hVN yield from T3 gener-
ation plants was 643  78 mg/kg FW of leaf.
Purification of recombinant hVN from N. benthamiana
Human vitronectin was purified from N. benthamiana using a
three-stage process based upon both affinity chromatography
and size exclusion filtration. Samples from each key step
(Figure 4) and all steps (Appendix S5) of the purification process
were separated by SDS-PAGE and visualized using Coomassie
Blue dye. N. benthamiana leaf proteins were solubilized in 9 M
urea to induce the conformational change in hVN that increases
heparin affinity (Figure 4, lane 1). Denatured hVN was resolved
from the majority of contaminating N. benthamiana leaf proteins
by heparin affinity chromatography (Figure 4, lane 2). The purity
of hVN after elution from the heparin affinity matrix was ~70%.
hVN was further purified using metal affinity chromatography
(Figure 4, lane 3). The purity of hVN after elution from the metal
affinity matrix with 150 mM imidazole was ~80%–90%. hVN was
separated from low molecular weight (<30 kDa) contaminants
and concentrated to ~0.5 mg/mL using centrifugal ultrafiltration
T3-1    T3-2    T3-3      50      100     200    400    500    
hVN standard (ng)
50
3       4      5      6       7     
Days postethanol
application
0.1 0.25  0.5   1.0     2.0
% ethanol
103
77
50
103
77
(a)
(c)
(b)
Figure 3 Time course and dose–response of ethanol activation for
maximal INPACT-based hVN expression and crude yield estimation.
Detached leaves of elite T0 generation INPACT line, T0-2, were activated in
liquid MS0 media containing ethanol. For time-course kinetics, leaves were
incubated in 0.5% (v/v) ethanol solution and sampled 3, 4, 5, 6, and
7 days postactivation (Panel a). For dose–response, leaves of line T0-2 were
incubated in different concentrations (0.1, 0.25, 0.5, 1.0 and 2.0% v/v) of
ethanol and sampled 5 days postactivation (Panel b). Samples in Panels a
and b were extracted under nondenaturing conditions and TSP was
normalized by Bradford protein assay. TSP (5 lg) was separated by SDS-
PAGE. For estimation of crude hVN yields in elite INPACT plants, detached
leaves from three batches (marked T3-1, T3-2 and T3-3) of T3 generation
plantlets (eight plants from each T2 parental line) were incubated in 0.5%
(v/v) ethanol solution and sampled 5 days postactivation (Panel c). TSP was
extracted under denaturing conditions. TSP (5 lg) was separated by SDS-
PAGE. A standard curve of hVN (Promega) ranging from 50 to 500 ng was
included for comparative yield estimates. Levels of hVN expression were
determined by immunoblotting. Immunoblot signals were detected and
measured using a ChemiDoc imaging system (Bio-Rad). Molecular weights
marked in kDa.
Table 1 Estimation of crude hVN yields in T3 generation INPACT plants
Yield (mg hVN/kg FW leaf)
T3 Generation plants Experiment 1 Experiment 2 Experiment 3 Mean  Standard Error
Batch T3-1 370.9 973.5 385.6 577  162
Batch T3-2 874.0 923.2 330.8 709  155
Batch T3-3 581.6 740.1 605.2 642  40
Average overall yield 643  78
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(Figure 4, lane 4). The purity of concentrated hVN was estimated
to be >90% at a final yield of between 30 and 128 mg/kg FW of
transgenic N. benthamiana leaf.
The identity of the purified protein from transgenic N. ben-
thamiana leaf was confirmed by N-terminal amino acid sequenc-
ing (Figure 5). No amino acid was detected on the fifth of seven
cycles of Edman degradation. However, the presence of Cys-S-b-
propionamide (Cys-S-Pam), the product of cysteine alkylation by
acrylamide under alkaline conditions, after the fifth Edman
degradation cycle, suggested the presence of a cysteine residue.
The resulting amino terminal sequence is identical to that
predicted following cleavage of the native 19-amino acid hVN
secretion signal (Figure 5).
Adhesive properties of plant-made hVN
The capacity of plant-made hVN to promote cell adhesion in
tissue culture was assessed using murine fibroblast cells (BALB-C/
3T3) (Figure 6a). Commercial, plasma-derived hVN (Promega)
was used as a control. Fibroblast binding increased with
increasing concentrations of both plant-made hVN and commer-
cial hVN. Maximum fibroblast adhesion (4 9 104 cells/well) was
observed at 0.4 lg hVN/cm2, and half-maximum fibroblast
adhesion occurred at ~0.05 lg hVN/cm2. The capacity of plant-
made hVN to promote fibroblast adhesion was statistically
equivalent to that of the commercial product over all concentra-
tions tested (P > 0.05).
Plant-made, purified hVN was stored for 7 weeks as a liquid at
4 °C, a frozen liquid at 80 °C, and freeze dried powder at
80 °C to determine the effects of long-term storage on protein
activity. The capacity of plant-made hVN to promote cell adhesion
in tissue culture after storage was compared with commercial,
plasma-derived hVN (Promega) (Figure 6b). Maximum fibroblast
adhesion for all hVN forms was observed at ~1.0 lg hVN/cm2.
Half-maximum fibroblast adhesion for stored plant-derived hVN
was ~0.2 lg hVN/cm2, compared to ~0.1 lg hVN/cm2 for the
commercial control. The concentrations of both commercial and
plant-made hVN that promoted maximum and half-maximum cell
adhesion were significantly higher than was observed in
Figure 6a, most likely because of variations in tetrazolium salt
uptake by cells using MTT [3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide] versus MTS [3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetra-
zolium]. Of the three conditions tested, storage of plant-made
hVN as a frozen liquid at 80 °C was the most effective at
retaining adhesion promoting activity. Activity of hVN stored in
this manner was statistically equivalent to the commercial product
in the range of 0.2–1.6 lg/cm2.
Discussion
Vitronectin is primarily used to promote cell attachment and
proliferation in vitro but also has other therapeutic and nonther-
apeutic applications. These applications, however, are limited by
the high cost of the native protein due to the extensive
purification and serological testing required to ensure the
absence of bloodborne pathogens. As such, in planta production
of recombinant hVN that is functionally equivalent and free from
animal pathogens by virtue of its source offers a cost-effective
alternative. We have previously demonstrated inducible produc-
tion of recombinant hVN in transgenic N. benthamiana plants
using the In Plant ACTivation (INPACT) platform (Dugdale et al.,
2013). Soil-acclimatized plants or detached leaves were activated
with ethanol, and maximal hVN expression was detected by
immunoblotting 4–5 days postapplication. Recombinant hVN
was partially purified from leaves using heparin affinity chro-
matography, and crude yields were estimated at ~100 mg hVN/
kg FW of leaf. In the present study, we have dramatically
improved hVN yield by modification of the INPACT platform,
developed an efficient recombinant hVN purification protocol,
and demonstrated that recombinant hVN produced in transgenic
N. benthamiana is functionally equivalent to commercial, human
plasma-derived VN.
The INPACT platform provides the benefits of high-level,
transient transgene expression in a stably transformed plant,
whereby extrachromosomal copies of the INPACT transgene
expression cassette are released, amplified, and transcribed only
in the presence of ethanol and the Rep/RepA activator proteins.
However, transient overexpression of heterologous genes can
trigger PTGS, an innate plant pathogen defence mechanism that
can significantly reduce steady state levels of recombinant protein
accumulation (Voinnet, 2001; Voinnet et al., 1998; Waterhouse
M            1               2                3                 4
103
81
47
34
27
17
Figure 4 Purification of recombinant hVN from N. benthamiana using a
three-stage extraction protocol. Total leaf protein solubilized in 9 M urea
(lane 1) was passed through a column containing Heparin Sepharose 6
Fast Flow resin and bound hVN eluted under high salt (500 mM NaCl)
conditions (lane 2). HIS-tagged hVN was then immobilized in TALON
Superflow Metal Affinity Resin and eluted using imidazole (lane 3). Plant-
made hVN was further subjected to size exclusion filtration using an
Amicon Ultra Centrifugal Filter (Ultracel-30K) in order to remove low
molecular weight protein contaminants and concentrate the product (lane
4). Protein samples representing each major step of the 3-stage extraction
protocol were electrophoresed through a 12% SDS-polyacrylamide gel
and stained with Coomassie Brilliant Blue R-250. M = prestained SDS-
PAGE standards, low range (Bio-Rad). Molecular weights marked in kDa.
MAPLRPLLILALLAWVALA /DQESCKG…
DQES─KG…
Figure 5 Comparison of the N-terminal sequence of plant-made hVN
with native hVN. The native hVN 19 amino acid secretion signal is
underlined and cleavage site marked (/). The blank amino acid read at
position 5 of plant-derived hVN is marked (─).
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et al., 1998). In order to overcome this, virus-encoded suppres-
sors of PTGS can be co-expressed with the gene of interest
(Voinnet et al., 1999). One such suppressor, p19 from Tomato
bushy stunt virus (TBSV), is known to sequester double-stranded,
small interfering RNA duplexes with high affinity, and co-
expression of this protein has been shown to significantly increase
transient heterologous gene expression (Sainsbury and Lomonos-
soff, 2008; Sainsbury et al., 2009). However, p19 itself is
phytotoxic and the generation of stably transformed plants
expressing p19 is challenging (Scholthof, 2007). While a recom-
binant p19 mutant (R43W) that does not induce phytotoxicity has
been developed (Saxena et al., 2011), this mutant form confers
only a modest (1.7-fold) increase in transgene expression levels.
Therefore, in order to fully exploit the benefits of the TBSV p19
protein in transgenic plants, we integrated ethanol-inducible
expression of the TBSV p19 gene into the INPACT platform for
the production of hVN. We observed low level, ‘leaky’ p19
transcription in the absence of ethanol induction but there was
no evidence of a negative impact upon phenotypic parameters
such as plant growth or development in the T0 to T3 generation
events. Further, we demonstrated that co-expression of p19 and
hVN increased recombinant hVN accumulation up to sixfold,
relative to the unmodified INPACT platform. This suggests that
PTGS is likely a limiting factor for INPACT-based recombinant
protein expression, but it can be overcome by inducible expres-
sion of a PTGS suppressor gene.
Intracellular targeting of recombinant proteins can significantly
influence the steady state levels to which they accumulate in
planta (Harrison et al., 2011; Streatfield et al., 2003). We
previously tested whether localized accumulation of recombinant
hVN in intracellular compartments greatly influenced its yield, by
targeting the protein to the cytoplasm, endoplasmic reticulum
(ER), apoplast, mitochondria or chloroplast. We found that hVN
retention in the ER resulted in maximum accumulation in
N. tabacum leaves (results not shown). Native hVN is glycosylated
at three sites which accounts for as much as 30% of the mass of
the mature protein (Schvartz et al., 1999), and changes in hVN
glycosylation alter its ability to form multimers and bind collagen
(Sano et al., 2007). However, glycosylation does not appear
essential for some of its biological activities as glycan removal can
increase collagen binding (Sano et al., 2007) and bacteria-made
VN has been used in chemically defined animal cell culture
systems (Chen et al., 2011). In the present study, the native hVN
amino-terminal secretion signal was preserved so that the
recombinant protein would enter the ER and an ER retention
signal (KDEL) added to the carboxyl-terminus of hVN to enhance
accumulation.
We have developed a small-scale production system using
leaves harvested from transgenic plants maintained in vitro and
activated with ethanol in solution. Elite T0 generation N. ben-
thamiana INPACT events expressing high levels of recombinant
hVN were micro-propagated in tissue culture using a rapid axillary
shoot induction method (Deo et al., 2015) that allowed gener-
ation of ~200 individual plants. We routinely produced ~150 g of
N. benthamiana leaf mass per week using a rotating subculture
system and accumulated >3 kg of leaves in a 5-month period.
Detached leaves were activated in tissue culture containing a
liquid growth media supplemented with 0.5% (v/v) ethanol and
harvested for purification after 5 days when hVN accumulation
was at its peak. Activated leaves could be stored at 80 °C or
used immediately for hVN extraction.
Laboratory-scale purification of recombinant hVN was routinely
undertaken using 10–30 g of N. benthamiana leaves, but we
have successfully scaled up purification to 100 g quantities of
leaves in the present study. Interestingly, higher plants encode
(a)
(b)
Figure 6 Adhesive properties of plant-made hVN and effects of long-
term storage. Panel (a): The ability of plant-made hVN (open circles) to
promote the attachment of BALB-C/3T3 cells in serum-free medium to
tissue culture plasticware was compared to commercial, plasma-derived
hVN (closed circles). MTS absorbance readings at 490 nm are directly
proportional to the number of viable cells bound to the plasticware
surface. Panel b: Plant-made hVN was stored long term for 7 weeks as (i) a
liquid at 4 °C (open triangles), (ii) frozen liquid at 80 °C (open circles) or
(iii) lyophilized at 80 °C (closed triangles) and its ability to promote the
attachment of BALB-C/3T3 cells to tissue culture plasticware compared to
commercial, plasma-derived hVN (closed circles). MTT absorbance
readings at 570 nm are directly proportional to the number of viable cells
bound to the plasticware surface. Samples were analysed in triplicate, and
error bars indicate mean  standard deviation.
ª 2017 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd., 16, 394–403
Production of human vitronectin in plants 399
hVN analogues that function in plasma membrane–cell wall
adhesion (Zhu et al., 1993), bacterium–plant interaction (Wagner
and Matthysse, 1992) and pollen tube extension (Sanders et al.,
1991). One such protein, tobacco PVN1 (plant vitronectin-like 1),
is predominantly localized to the cell wall and has been shown to
bind both glass and heparin (Zhu et al., 1994). N. benthamiana
encodes a protein with 97% similarity to tobacco PVN1 (Nakasugi
et al., 2013) and contains an RYD motif with functional similarity
to the hVN RGD binding domain. Therefore, a second affinity
chromatography step (i.e. immobilized metal) was included in our
hVN purification process to minimize the likelihood of contam-
ination with N. benthamiana PVN1. We observed that recombi-
nant hVN yield was significantly affected by the age and
physiological status of plants in vitro. Leaves obtained from
freshly propagated N. benthamiana in vitro plants were generally
larger, appeared healthier and yielded the maximum level of
>90% pure recombinant hVN (128 mg/kg FW). In contrast, leaves
from the third harvest and beyond were generally smaller, more
chlorotic and had reduced hVN content (30 mg/kg FW).
Optimization of the molecular features of the INPACT platform
resulted in a sixfold increase in recombinant hVN accumulation
compared to the unmodified INPACT platform, and the develop-
ment of an efficient extraction protocol produced a plant-made
hVN of >90% estimated purity that was functionally equivalent to
the native human protein. While transient agroinfiltration-based
expression remains the preferred method for rapid recombinant
protein production in plants, there is still an obvious need for
extended, large-scale production capacities. The elite transgenic
INPACT plants and the seed bank generated in this study
represent a permanent genetic resource for the consistent and
high-level production of this valuable protein into the future.
Materials and methods
Vector construction
The CaMV 35S promoter (35SP) controlling expression of the
hygromycin B phosphotransferase (hph) selection gene in
pCAMBIA1300 was replaced with the nopaline synthase gene
promoter (nosP). The nosP and hph genes were amplified by PCR
and fused using overlapping PCR with the following primer pairs;
hph-F (50-TCTCCGCTCATGATCATGAAAAAGCCTGAACTCACC
GCGA-30) and hph-R (50-CTCGAGCTTGTCGATCGACAGATCCG
GTCGGCATC-30), and nosP-F (50-GAATTCTCTAGACACGTGAGA
TCCGGTGCAGATTATTTGGATTGAGAGTG-30) and nosP-R (50-TT
CAGGCTTTTTCATGATCATGAGCGGAGAATTAAGGGAG-30). The
resulting nosP-hph fusion was ligated into pCAMBIA1300 using
XhoI and EcoRI restriction sites. An INPACT expression cassette
encoding the GUS reporter gene was excised from pINPACT-GUS
(Dugdale et al., 2013) and ligated into the above vector using
EcoRI/HindIII restriction sites. The nearly complete INPACT cassette
encoding hVN (with native secretion signal, KDEL retention signal
and polyhistidine affinity tag) was then excised from pINPACT-
hVN (Dugdale et al., 2013) and ligated into the vector using SwaI/
PacI restriction sites to create pINPACT-hVN-nos. Wild-type TBSV
p19 (GenBank Accession M21958.1) was codon modified to
include human and N. tabacum first preferred codons and an 84-
bp synthetic intron (syntron; Dugdale et al., 2013) between the
AG/GT at nucleotide position 201. The modified p19 gene was
chemically synthesized by GeneArt (Life Technologies, Mount
Waverley, VIC, Australia) and ligated upstream of the nopaline
synthase gene terminator (nosT) in the plasmid pACN2 using
unique PstI restriction sites. The final INPACT hVN expression
vector was constructed by three-way ligation of the following
fragments: Pmll/XbaI digested pINPACT-hVN-nos backbone, PmlI/
BamHI digested alcA promoter sequence and BamHI/XbaI
digested p19-nosT sequence from pACN2. The resulting vector
was designated pINPACT-hVN2 (Figure 1).
Construction of the vector pAlc-Rep/RepA, a pBIN-based vector
backbone containing (i) the TYDV Rep/RepA activator genes
downstream of the alcA promoter, (ii) the alcR transcription
factor gene under the transcriptional control of 35SP and (iii) the
neomycin phosphotransferase (nptII) resistance gene for kana-
mycin selection of transformed plant cells, has been previously
described (Figure 1; Dugdale et al., 2013).
Stable transformation of N. benthamiana
All vectors for stable transformation were mobilized into
Agrobacterium tumefaciens (strain LBA4404) by electroporation.
A. tumefaciens-mediated transformation of N. benthamiana leaf
discs and their regeneration were as described by Horsch et al.
(1985). Transgenic plants containing the pAlc-Rep/RepA cassette
were selected and regenerated in media containing kanamycin
(200 lg/mL). Ethanol-inducible expression of the Rep/RepA genes
in these lines was assessed by RT-PCR. Leaves from event NbAlc-1
were subsequently used for supertransformation with recombi-
nant A. tumefaciens harbouring pINPACT-hVN2. To ensure
supertransformed plants contained both pAlc-Rep/RepA and
pINPACT-hVN2 expression cassettes and were independent
events, plantlets were excised from different leaf pieces and
regenerated in media containing both kanamycin (200 lg/mL)
and hygromycin (25 lg/mL). In vitro or soil-acclimatized plants
were maintained in a controlled environment chamber with a 16-
h photoperiod at 25 °C and grown to the 8- to 10-leaf stage prior
to harvest and ethanol activation.
Reverse transcription PCR (RT-PCR)
Leaf samples were immediately snap-frozen in liquid nitrogen
following harvesting. Tri reagent (Sigma-Aldrich, Castle Hill, NSW,
Australia) was used to extract total RNA from tissue according to the
manufacturer’s instructions and the method of Azevedo et al.
(2003). Oligo (dT) 18 primer was used to synthesize first-strand
complementary DNA from total RNA using M-MLV Reverse Tran-
scriptase (Promega, Alexandria, NSW, Australia) according to the
manufacturer’s instructions. Reactions were also prepared without
reverse transcriptase toconfirmtheabsenceof contaminatinggDNA.
PCRswere performedusingGoTaqGreenmastermix (Promega) and
the following cycling conditions 94 °C for 5 min followed by 29
cycles of94 °Cfor30 s,55 °Cfor30 s,72 °Cfor30 s, and72 °Cfor
10 min. Primer sets were as follows; TYDV Rep/RepA–Rep/RepA-F
(50-TCAGACTGGCAACCTATT-30) and Rep/RepA-R (50-GCGAACT
ATTATCCAGAC-30), wild-type TBSV p19–P19-F (50-CCATGGAA
AGGGCTATTCAGGGAAATGATG-30) and P19-R (50-GAGCTCTC
ACTCGGATTCTTTCTCAAAGTC-30), and actin–Actin-F (50-CTATTCT
CCGCTTTGGACTTGGCA-30) and Actin-R (50-AGGACCTCAGGAC
AACGGAAACG-30).
Ethanol activation
The INPACT platform was activated in whole or detached leaves
using three different methods. For soil-acclimatized plants, 5% (v/
v) ethanol in water was applied as a foliar spray and root drench.
For rapid screening of transgenic lines, leaves of in vitro N. ben-
thamiana plants were ethanol activated in sealed Petri dishes.
Leaves were placed adaxial side down onto solid MS0 media
containing a 5-mm-wide and 5-mm-deep well filled with 3 mL of
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5% (v/v) ethanol. For time-course kinetics, dose–response, yield
estimates and laboratory-scale hVN purification, leaves from
tissue culture N. benthamiana plants were harvested, placed in a
sterile 500-mL tissue culture vessel, and immersed in 150 mL of
MS0 media (Murashige and Skoog, 1962) containing 0.5% (v/v)
ethanol. The vessel was agitated on a flatbed rotary shaker
(60 rpm) for 5 days with a 16-h photoperiod at 25 °C. For time-
course kinetics, sampling time was varied (3, 4, 5, 6, and 7 days
postactivation), and for dose–response, ethanol concentration
was varied (0.1%, 0.25%, 0.5%, 1.0%, and 2.0% (v/v)). Excess
liquid was removed prior to extraction or freezing in liquid
nitrogen and storage at 80 °C.
Purification of hVN from N. benthamiana leaves
Leaves were ground to a powder in liquid nitrogen using a mortar
and pestle. For rapid hVN detection, TSP was extracted in five
volumes of either 200 mM phosphate buffer (pH 7) or extraction
buffer (9 M urea, 50 mM phosphate, 10 mM b-mercaptoethanol,
pH 7) and separated by SDS-PAGE for immunoblotting. For
laboratory-scale purification, extraction buffer containing EDTA-
free Complete Protease Cocktail Inhibitor (Roche, Castle Hill, NSW,
Australia) was added to the leaf powder at a ratio of 7.5 mL per
gram FW. The concentration of urea was increased from 8 M (that
used to isolate hVN from blood plasma (Yatohgo et al., 1988)), to
9 M in order to compensate for high leaf water content. The
resulting slurry was agitated at 15 rpm on an orbital wheel shaker
for 15–30 min at room temperature. Larger plant debris was
removed by filtration through Miracloth (VWR, Murarrie, QLD,
Australia) prior to clarification by centrifugation at 20 000 g for
20 min at 20 °C. A Heparin Sepharose 6 Fast Flow (GE Healthcare,
Mansfield, QLD, Australia) column was prepared with a packed
bed volume equivalent to 1 mL/5 g starting leaf material and
equilibrated with three column volumes of HS buffer (8 M urea,
50 mM phosphate, pH 7). The supernatant was loaded directly
onto the equilibrated Heparin Sepharose. The Heparin Sepharose
was washed with five column volumes of HS buffer and bound
hVN eluted using five column volumes of HS Elution buffer (HS
Column buffer supplemented with 500 mM NaCl).
A column of TALON Superflow Metal Affinity Resin (Sigma)
was prepared with a packed bed volume equivalent to 1 mL/5 g
leaf material and equilibrated with three column volumes of HS
Elution buffer. The eluent from the Heparin Sepharose column
was loaded directly onto the equilibrated TALON column. The
column was washed with five column volumes of HS Elution
buffer and bound HIS-tagged hVN eluted using five column
volumes of TALON Elution buffer (HS Elution buffer supple-
mented with 150 mM imidazole).
An Amicon Ultra Centrifugal Filter unit (Ultracel-10K, Millipore)
was equilibrated using 3 mL of HS Elution buffer and centrifu-
gation at 5000 g for 5 min at 18 °C. The eluent from the
TALON column was diluted 1 : 2 with HS Elution buffer (to
decrease the imidazole concentration to 75 mM) then loaded
onto the Ultracel-10K filter and centrifuged at 5000 g for 10 min
at 18 °C. The filter was washed five to 6 times with 3–4 mL of HS
Elution buffer and centrifuged at 5000 g for 10 min at 18 °C
until the final retained volume was between 100 and 500 lL.
A Puradisc FP 30 PTFE, 0.2-lm sterile syringe filter (Thermo
Fisher, Scoresby, VIC, Australia) was equilibrated with 1 mL of HS
elution buffer. hVN retained after size exclusion filtration was
sterilized using the equilibrated filter. Purified plant-made hVN
was either stored short-term at 4 °C or long term at 80 °C with
or without freeze drying.
Samples (5 lL) from each step of the purification protocol were
collected and stored on ice prior to PAGE analysis. Purified plant-
made hVN was quantified using the Bradford Protein Assay
microtitre plate procedure (Bio-Rad, Regents Park, NSW, Aus-
tralia) according to the manufacturer’s instructions and known
amounts of commercial purified hVN (Promega). Absorbance at
595 nm was determined using a Beckman CoulterTM AD200 plate
reader, and samples were analysed in triplicate.
PAGE, immunoblotting, N-terminus sequencing and
yield estimation
PAGE and immunoblotting for detection of hVN was carried out
as described by Dugdale et al. (2013). For amino-terminal
sequencing, 3 lg of plant-made hVN was subjected to SDS-
PAGE, transferred to PVDF membrane and stained with Ponceau
dye. The major 75-kDa band was excised from the PVDF
membrane, and the first seven amino-terminal residues were
sequenced using an Applied Biosystems 494 Precise Protein
Sequencing System (Australian Proteome Analysis Facility, Mac-
quarie University, NSW). For yield estimation, Clarity Western ECL
substrate (Bio-Rad) was formulated according to the manufac-
turer and applied as a 1 : 10 dilution to the membrane. Signal
strength was detected using a ChemiDoc imaging system (Bio-
Rad) and yield calculated from a hVN standard curve ranging
from 50 to 500 ng. Average plant-made hVN yield is presented as
mean  standard error.
Cell adhesion assay
Plant-made and plasma-derived hVN (Promega) were diluted in
Dulbecco’s PBS (DPBS, Life Technologies) to concentrations
ranging between 1.6, 0.800, 0.400, 0.200, 0.100, 0.050,
0.02500, 0.0125 and 0 lg/cm2 in 100 lL. Wells of a Nunc
MaxiSorp flat-bottom 96-well plate (Sigma) were coated with
100 lL of each hVN dilution in triplicate. Plates were incubated
for 2 h at room temperature then rinsed 3 times with 250 lL of
DPBS per well. After rinsing, 200 lL of DPBS blocking solution
(DPBS with 2 mg/mL bovine serum albumin (BSA)) was added to
each well and the plate was incubated for 1 h at room
temperature. The BSA blocking solution was removed prior to
adding animal cells. Three-day-old BALB-C/3T3 cells were har-
vested by trypsinization and pelleted by centrifugation at 200 g
for 5 min at room temperature. Cells were resuspended in 1 mL
Dulbecco’s Modified Eagle Medium (DMEM) containing 10% (v/v)
foetal bovine serum (Life Technologies). Viable cell counts were
estimated using trypan blue exclusion dye (Life Technologies) and
cell concentrations adjusted to 4 9 105 cells/mL. An aliquot
(100 lL) of cell suspension (4 9 105 cells/mL) was added to each
hVN-coated well, and the plate was incubated at 37 °C with 5%
(v/v) CO2 for 1 h. Unattached cells were gently aspirated from
the wells using a multichannel pipette and the attached cells
gently washed 3 times with 250 lL of serum-free DMEM (Sigma)
per well. Cell densities were measured using either MTS or MTT
substrate methodologies. For MTS substrate, 100 lL of serum-
free DMEM and 20 lL of CellTiter 96 AQueous One Solution
Cell Proliferation Assay reagent (Promega) was added to each
well and incubated at 37 °C with 5% (v/v) CO2 for 1 h.
Absorbance at 490 nm (compared to absorbance at a reference
wavelength of 690 nm) was measured using a Beckman Coul-
terTM plate reader and data averaged using three replicates. Mean
absorbance at 490 nm versus the hVN concentration was plotted
in order to determine ED50. For the MTT substrate, 10 lL of MTT
(5 mg/mL) in DPBS was added to each well and incubated at
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37 °C with 5% (v/v) CO2 for 3–4 h until a dark precipitate
formed. The media were then aspirated and 200 lL of 100% (w/
v) DMSO added to each well in order to solubilize the precipitate.
Absorbance was measured at 570 nm (compared to an
absorbance at a reference wavelength of 630 nm) and plotted
against hVN concentration to determine ED50, as above.
Statistical analysis
One-way analysis of variance was performed to compare different
batch yields or different cell binding activities (P ˂ 0.05 was
considered significant). Data values were expressed as mean
standard error for yield estimates and mean  standard deviation
for cell attachment assays.
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